Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T14:17:00.267Z.
Consensus retrieved: 2026-10-06T12:18:50.738Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T14:17:00.267Z.
Quote observation: 2026-10-06T14:13:59.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 87a3ef4e55b06d985fb23947e4d9ae6563d80488a3a61227015f8099389db825
Forward PE Ratio (N/A) = Dated Quote Price ($1.63) / Consensus Forward EPS ($-2.88)
FORWARD PE RATIO
N/A
HCW Biologics Inc.
Market Cap
$564917.00
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| HCW Biologics Inc. (HCWB) | $564917.00 | N/A |
| CDT Equity Inc. (CDT)vs › | $685794.00 | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $814941.00 | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $880673.00 | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | N/A |
| Bone Biologics Corporation (BBLG)vs › | $898130.00 | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | N/A |
| Akanda Corp. (AKAN)vs › | $62816.00 | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.10M | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $31001.00 | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $1.63, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-2.88 | $-2.88 – $-2.88 | 1 | n/m |
| 2027-12-31 | $-2.64 | $-2.64 – $-2.64 | 1 | n/m |
| 2028-12-31 | $-2.10 | $-2.10 – $-2.10 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
